2015 Alzheimer's disease facts and figures
- PMID: 25984581
- DOI: 10.1016/j.jalz.2015.02.003
2015 Alzheimer's disease facts and figures
Abstract
This report discusses the public health impact of Alzheimer’s disease (AD), including incidence and prevalence, mortality rates, costs of care and the overall effect on caregivers and society. It also examines the challenges encountered by health care providers when disclosing an AD diagnosis to patients and caregivers. An estimated 5.3 million Americans have AD; 5.1 million are age 65 years, and approximately 200,000 are age <65 years and have younger onset AD. By mid-century, the number of people living with AD in the United States is projected to grow by nearly 10 million, fueled in large part by the aging baby boom generation. Today, someone in the country develops AD every 67 seconds. By 2050, one new case of AD is expected to develop every 33 seconds, resulting in nearly 1 million new cases per year, and the estimated prevalence is expected to range from 11 million to 16 million. In 2013, official death certificates recorded 84,767 deaths from AD, making AD the sixth leading cause of death in the United States and the fifth leading cause of death in Americans age 65 years. Between 2000 and 2013, deaths resulting from heart disease, stroke and prostate cancer decreased 14%, 23% and 11%, respectively, whereas deaths from AD increased 71%. The actual number of deaths to which AD contributes (or deaths with AD) is likely much larger than the number of deaths from AD recorded on death certificates. In 2015, an estimated 700,000 Americans age 65 years will die with AD, and many of them will die from complications caused by AD. In 2014, more than 15 million family members and other unpaid caregivers provided an estimated 17.9 billion hours of care to people with AD and other dementias, a contribution valued at more than $217 billion. Average per-person Medicare payments for services to beneficiaries age 65 years with AD and other dementias are more than two and a half times as great as payments for all beneficiaries without these conditions, and Medicaid payments are 19 times as great. Total payments in 2015 for health care, long-term care and hospice services for people age 65 years with dementia are expected to be $226 billion. Among people with a diagnosis of AD or another dementia, fewer than half report having been told of the diagnosis by their health care provider. Though the benefits of a prompt, clear and accurate disclosure of an AD diagnosis are recognized by the medical profession, improvements to the disclosure process are needed. These improvements may require stronger support systems for health care providers and their patients.
Similar articles
-
2014 Alzheimer's disease facts and figures.Alzheimers Dement. 2014 Mar;10(2):e47-92. doi: 10.1016/j.jalz.2014.02.001. Alzheimers Dement. 2014. PMID: 24818261
-
2016 Alzheimer's disease facts and figures.Alzheimers Dement. 2016 Apr;12(4):459-509. doi: 10.1016/j.jalz.2016.03.001. Alzheimers Dement. 2016. PMID: 27570871
-
2012 Alzheimer's disease facts and figures.Alzheimers Dement. 2012;8(2):131-68. doi: 10.1016/j.jalz.2012.02.001. Alzheimers Dement. 2012. PMID: 22404854
-
The costs of Alzheimer's disease and the value of effective therapies.Am J Manag Care. 2011 Nov;17 Suppl 13:S356-62. Am J Manag Care. 2011. PMID: 22214393 Review.
-
Dementia -- Caring, Ethics, Ethnical and Economical Aspects: A Systematic Review [Internet].Stockholm: Swedish Council on Health Technology Assessment (SBU); 2008 Jun. SBU Assessment No. 172. Stockholm: Swedish Council on Health Technology Assessment (SBU); 2008 Jun. SBU Assessment No. 172. PMID: 28876770 Free Books & Documents. Review.
Cited by
-
Human ApoE ɛ2 Promotes Regulatory Mechanisms of Bioenergetic and Synaptic Function in Female Brain: A Focus on V-type H+-ATPase.J Alzheimers Dis. 2016 Jun 18;53(3):1015-31. doi: 10.3233/JAD-160307. J Alzheimers Dis. 2016. PMID: 27340853 Free PMC article.
-
Rare Functional Variant in TM2D3 is Associated with Late-Onset Alzheimer's Disease.PLoS Genet. 2016 Oct 20;12(10):e1006327. doi: 10.1371/journal.pgen.1006327. eCollection 2016 Oct. PLoS Genet. 2016. PMID: 27764101 Free PMC article.
-
Whole genome methylation sequencing in blood from persons with mild cognitive impairment and dementia due to Alzheimer's disease identifies cognitive status.bioRxiv [Preprint]. 2024 Sep 27:2024.09.26.615196. doi: 10.1101/2024.09.26.615196. bioRxiv. 2024. Update in: Alzheimers Dement. 2025 Jan 1. doi: 10.1002/alz.14474 PMID: 39386499 Free PMC article. Updated. Preprint.
-
Presenilin 1 transgene addition to amyloid precursor protein overexpressing transgenic rats increases amyloid beta 42 levels and results in loss of memory retention.BMC Neurosci. 2016 Jul 7;17(1):46. doi: 10.1186/s12868-016-0281-8. BMC Neurosci. 2016. PMID: 27388605 Free PMC article.
-
Cognitive Health Assessment and Establishment of a Virtual Cohort of Dementia Caregivers.Dement Geriatr Cogn Dis Extra. 2016 Mar 22;6(1):98-107. doi: 10.1159/000444390. eCollection 2016 Jan-Apr. Dement Geriatr Cogn Dis Extra. 2016. PMID: 27099613 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical